The Edge of Horizon Therapeutics

I would say they're both in the over 90% likely to be successfully completed. The annualized rate of return is a little bit lower in this, implying that there's less risk. We haven't heard yet from the FTC in the case of Horizon. All things, all indications are that I actually give this one the edge.